NeuBase Therapeutics, Inc. Restructuring Charges
NeuBase Therapeutics, Inc. reported Restructuring Charges of $372.21 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2023-11-09
- NeuBase Therapeutics, Inc. restructuring charges for the quarter ending 2023-09-30 was $365.48K.
- NeuBase Therapeutics, Inc. restructuring charges for the quarter ending 2023-06-30 was $0.00.
- NeuBase Therapeutics, Inc. restructuring charges for the quarter ending 2023-03-31 was $6.73K.
- NeuBase Therapeutics, Inc. restructuring charges for the quarter ending 2022-12-31 was $652.45K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2023-09-30 | $365.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $365.48K derived: sum of 2 quarters · filed 2023-11-09 | $372.21K 10-Q · filed 2023-11-09 | $1.02M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | $6.73K 10-Q · filed 2023-08-14 | $659.18K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2023-03-31 | $6.73K 10-Q · filed 2023-05-11 | $659.18K derived: sum of 2 quarters · filed 2023-06-05 | ||
| 2022-12-31 | $652.45K 10-QT · filed 2023-06-05 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-06-05 | ||
| 2021-12-31 | $0.00 10-QT · filed 2023-06-05 |